IBERE PHARMACEUTICALS Business Finance Contracts & Agreements
14 Contracts & Agreements
- Note Agreements (1 contract)
- Purchase Agreements (2)
- Registration Rights Agreements (2)
- Share Agreements (1)
- Stock Agreements (3)
- Subscription Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (2)
- Sponsor Warrants Purchase Agreement, dated February 25, 2021, by and between the Company and the Sponsor (Filed With SEC on March 3, 2021)
- Registration Rights Agreement, dated February 25, 2021, by and between the Company and the Sponsor (Filed With SEC on March 3, 2021)
- Investment Management Trust Agreement, dated February 25, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on March 3, 2021)
- Warrant Agreement, dated February 25, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on March 3, 2021)
- Underwriting Agreement, dated February 25, 2021, by and among the Company and Raymond James & Associates, Inc (Filed With SEC on March 3, 2021)
- Form of Private Placement Warrants Purchase Agreement between the Registrant and the sponsor (Filed With SEC on February 9, 2021)
- Securities Subscription Agreement, dated November 15, 2020, between the Registrant and the sponsor (Filed With SEC on February 9, 2021)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on February 9, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on February 9, 2021)
- Promissory Note, dated November 15, 2020, issued to the sponsor (Filed With SEC on February 9, 2021)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on February 9, 2021)
- Specimen Warrant Certificate (Filed With SEC on February 9, 2021)
- Specimen Class A Ordinary Share Certificate (Filed With SEC on February 9, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 9, 2021)
